Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.PPD has opened a new office in Istanbul, Turkey, continuing the growth of its Phase II-IV clinical development services in Eastern Europe. PPD will provide clinical monitoring services in key therapeutic areas from this location.
Subscribe to our email newsletter
The new office is expected to strengthen PPD’s presence in Eastern Europe beyond Russia and Ukraine, countries where the company is expanding through its pending acquisition of InnoPharm. PPD has targeted Eastern Europe, an important, high-growth market for clinical trials, for its expansion.
Fred Eshelman, CEO of PPD, said: “Eastern Europe offers recruitment opportunities and quality investigators, and our Istanbul office is an important part of our strategic growth in this region. We plan to continue to expand in areas where there is high demand for our global experience and therapeutic expertise.”